DRUG ENFORCEMENT ADMINISTRATION see also Department of Justice

Amendments

Drugs: improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), S7494 [26OC], H8212 [16NO]

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (H.R. 2578), H3643 [1JN], H3674, H3675, H3676, H3677, H3678, H3680, H3681, H3682, H3683, H3684, H3685, H3686, H3687, H3688, H3689, H3691, H3692, H3693, H3694, H3695, H3696, H3701, H3702, H3703, H3704, H3706, H3707, H3708, H3709, H3716, H3718, H3721, H3722, H3724, H3725, H3727, H3728, H3729, H3730, H3732, H3733, H3734, H3735, H3736, H3737, H3738, H3739, H3740, H3741, H3742, H3743, H3744, H3745, H3747, H3748, H3750, H3752, H3753, H3754, H3760, H3761, H3762 [2JN], H3790, H3791, H3793, H3794, H3795, H3796, H3797, H3798, H3799, H3801, H3803, H3804, H3805, H3807, H3808 [3JN]

Articles and editorials

DEA and NSA Team Up to Share Intelligence, Leading to Secret Use of Surveillance in Ordinary Investigations (excerpt), S3164 [20MY]

NSA Is Giving Your Phone Records to the DEA. And the DEA Is Covering It Up (excerpt), S3165 [20MY]

Bills and resolutions

ATF: abolish and transfer functions relating to firearms, explosives, arson, violent crime, and terrorism to the FBI and transfer functions relating to alcohol and tobacco smuggling to the DEA (see H.R. 1329), H1613 [4MR]

Crime: deploy Border Patrol agents and increase number of DEA and ATF agents along U.S. border to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (see H.R. 43), H37 [6JA]

Dept. of Justice: improve enforcement efforts relative to prescription drug diversion and abuse (see S. 483), S982 [12FE] (see H.R. 471), H530 [22JA]

——— prohibit use of amounts from Asset Forfeiture Fund for DEA Domestic Cannabis Suppression/Eradication Program (see H.R. 3518), H6074 [16SE]

Drugs: clarify how synthetic drugs known as analogues are to be regulated (see H.R. 3537), H6136 [17SE]

——— decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol (see H.R. 1013), H1084 [20FE]

——— establish a list of synthetic drugs known as analogues and prohibit most importation, amend sentencing for violations, and improve regulation relative to such analogues (see H.R. 4229), H9270 [10DE]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (see S. 481), S982 [12FE] (see H.R. 639), H702 [2FE]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (see S. 36), S11 [6JA] (see S. 1327), S2850 [13MY] (see H.R. 1186), H1499 [27FE]

——— increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (see S. 1431), S3237 [21MY]

——— increase penalties for fentanyl trafficking (see S. 2027), S6605 [10SE] (see H.R. 4183), H9011 [3DE]

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (see S. 2131), S7124 [5OC] (see H.R. 2578), H3581 [29MY]

——— making appropriations (H.R. 2578), consideration (see H. Res. 287), H3641 [1JN]

U.S. Intelligence Professionals Day: designate (see S. Res. 229), S5526 [23JY]

Cost Estimates

Improving Regulatory Transparency for New Medical Therapies Act (H.R. 639): CBO, H1641 [16MR]

Letters

Ensuring Patient Access and Effective Drug Enforcement Act: Representative Goodlatte, Committee on the Judiciary (House), H2330 [21AP]

——— Representative Upton, Committee on Energy and Commerce (House), H2330 [21AP]

Improving Regulatory Transparency for New Medical Therapies Act: Representative Goodlatte, Committee on the Judiciary (House), H1640 [16MR]

——— Representative Upton, Committee on Energy and Commerce (House), H1640 [16MR]

Motions

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (H.R. 2578), H3815 [3JN]

Remarks in House

Civil liberties: prohibit funding to enable bulk collection of personal communications records, H3727 [2JN]

Dept. of Justice: child abuse assistance programs funding through reductions in DEA funding, H3703 [2JN]

——— improve enforcement efforts relative to prescription drug diversion and abuse (H.R. 471), H2329–H2332 [21AP]

——— prohibit funding for collection of information about individuals attending gun shows, H3798, H3799 [3JN]

——— prohibit funding to prevent States from implementing laws that authorize the use, distribution, possession, or cultivation of industrial hemp, H3736, H3737 [2JN], H3790, H3791 [3JN]

Drugs: decriminalize marijuana at the Federal level and leave States the power to regulate marijuana, H7031 [21OC], H8284 [18NO]

——— decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol, H985 [12FE]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), H1638–H1641 [16MR]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), Senate amendment, H8212, H8213 [16NO]

——— prohibit funding to investigate physicians prescribing certain narcotic drugs for maintenance or detoxification treatment, H3734, H3735 [2JN]

LSC: funding through reductions in DEA funding, H3704, H3705 [2JN], E850 [8JN]

Rosenberg, Chuck: question of fitness to serve as DEA Administrator relative to comments on medical marijuana, H8284 [18NO]

Science, Depts. of Justice and Commerce, and related agencies: across-the-board funding reduction, H3728 [2JN], H3799–H3801 [3JN]

——— making appropriations (H.R. 2578), H3584 [1JN], H3660–H3755 [2JN], H3781–H3817 [3JN], E827 [3JN], E839 [4JN], E850 [8JN]

——— making appropriations (H.R. 2578), consideration (H. Res. 287), H3652–H3659 [2JN]

——— making appropriations (H.R. 2578), motion to recommit, H3815, H3816 [3JN]

——— prohibit funding for contracts with offerors or principals of offerors convicted of certain crimes within a certain period, H3742 [2JN]

——— prohibit funding to lease or purchase new light duty vehicles except in accordance with Presidential memorandum on Federal fleet performance, H3725 [2JN]

——— prohibit funding to States or local governments with laws, policies, or procedures in contravention of Federal immigration laws, H3743, H3744 [2JN], H3804, H3805 [3JN]

Remarks in Senate

Drugs: decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol, S7620 [29OC]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (H.R. 639), S7495 [26OC]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (S. 1327), S4337 [22JN]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (S. 36), S19 [6JA]

Government: impact of sequestration on Executive departments and independent agencies services, S4172 [16JN]

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (H.R. 2578), S4012 [10JN], S4122 [15JN]

——— making appropriations (S. 2131), S7127 [5OC], S7130 [6OC]

U.S. Intelligence Professionals Day: designate (S. Res. 229), S5559 [23JY]

Reports filed

Consideration of H.R. 2578, Science, Depts. of Justice and Commerce, and Related Agencies Appropriations: Committee on Rules (House) (H. Res. 287) (H. Rept. 114–135), H3641 [1JN]

Ensuring Patient Access and Effective Drug Enforcement Act: Committee on Energy and Commerce (House) (H.R. 471) (H. Rept. 114–85), H2318 [20AP]

Improving Regulatory Transparency for New Medical Therapies Act: Committee on Energy and Commerce (House) (H.R. 639) (H. Rept. 114–41), H1660 [16MR]

——— Committee on Health, Education, Labor, and Pensions (Senate) (S. 481), S7101 [1OC]

Science, Depts. of Justice and Commerce, and Related Agencies Appropriations: Committee on Appropriations (House) (H.R. 2578) (H. Rept. 114–130), H3581 [29MY]

——— Committee on Appropriations (Senate) (H.R. 2578) (S. Rept. 114–66), S4202 [16JN]

Rulings of the Chair

Science, Depts. of Justice and Commerce, and related agencies: making appropriations (H.R. 2578), H3744 [2JN], H3799 [3JN]

Tables

Science, Depts. of Justice and Commerce, and related agencies appropriations (H.R. 2578), H3662–H3666 [2JN]

Texts of

H. Res. 287, consideration of H.R. 2577, Depts. of Transportation and HUD and related agencies appropriations and H.R. 2578, science, Depts. of Justice and Commerce, and related agencies appropriations, H3652 [2JN]

H.R. 471, Ensuring Patient Access and Effective Drug Enforcement Act, H2329 [21AP]

H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act, H1638 [16MR], H8212 [16NO]

S. Res. 229, U.S. Intelligence Professionals Day, S5537 [23JY]